Use of sildenafil with inhaled nitric oxide in the management of severe pulmonary hypertension.
Saygili
Arda
A
Division of Pediatric Cardiology, Gazi University Medical School, Ankara, Turkey. arda@gazi.edu.tr
Canter
Berna
B
Iriz
Erkan
E
Kula
Serdar
S
Tunaoğlu
Fatma Sedef
FS
Olguntürk
Rana
R
Ozdoğan
Mehmet Emin
ME
D000280:Administration, Inhalation; D001794:Blood Pressure / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D006332:Cardiomegaly / Q000150:complications / Q000601:surgery; D002648:Child; D004334:Drug Administration Schedule; D004562:Electrocardiography / Q000379:methods; D006345:Heart Septal Defects, Ventricular / Q000150:complications / Q000601:surgery; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D007442:Intubation, Intratracheal / Q000379:methods; D008297:Male; D009569:Nitric Oxide / Q000627:therapeutic use*; D010879:Piperazines / Q000008:administration & dosage / Q000627:therapeutic use*; D011182:Postoperative Care / Q000379:methods; D011687:Purines; D012720:Severity of Illness Index; D000068677:Sildenafil Citrate; D013450:Sulfones; D013997:Time Factors; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*
D001993:Bronchodilator Agents; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D009569:Nitric Oxide; D000068677:Sildenafil Citrate